Skip to content
SB
Company

Updated:

Strongbridge Biopharma plc

Strongbridge Biopharma plc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001634432, and its reported...

Overview

Strongbridge Biopharma plc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001634432, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2021-03-03, it reported annual revenue of USD 30,731,000; net income of USD -45,075,000; total assets of USD 121,100,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Strongbridge Biopharma plc
Former names in filing history
Cortendo AB (2015-02-25 to 2015-08-28)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Trevose, PA, United States
Incorporated in
Ireland
SEC CIK
0001634432

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2020USD$30.7M-$45.1M$121.1M$87.5M-$38.1M
FY2019USD$21.7M-$49.5M$117.6M$57.0M-$44.8M
FY2018USD$18.0M$31.9M$170.3M$122.5M-$84.6M
FY2017USD$7.0M-$113.5M$103.9M$57.5M-$45.3M

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
10-Q10-Q
8-K8-K
8-K8-K
SC 13G—Form SC 13G
8-KFORM 8-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Strongbridge Biopharma plc in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Strongbridge Biopharma plc | Trevose Company | Altss